Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Thymosin beta-4 promotes hair growth in mice.

A man was poisoned with thallium, treated successfully, but still had some nerve issues after 6 months.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Sex hormones affect liver fat and metabolic health differently in men and women.

Low levels of vitamin B12, iron, ferritin, and zinc are linked to hair loss in Iraqi women.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Low-sulfur hair syndrome can cause UVB sensitivity and testicular failure.

A gluten-free diet and removing the parathyroid adenoma helped a girl with coeliac disease and high calcium levels start puberty.

SLHA can be hard to diagnose and needs teamwork between specialists.

Physical symptoms in depression can reveal underlying medical conditions.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Diet can prevent bone issues but not hair loss in mice lacking vitamin D receptors.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.